These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2759729)

  • 21. Oestrone sulphatase activity in normal and malignant breast tissues: relationship with tumour location.
    Chapman O; Purohit A; Wang DY; Ghilchik MW; Reed MJ
    Anticancer Res; 1995; 15(4):1467-71. PubMed ID: 7654035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oestrogen production in adipose tissue from normal women and women with endometrial cancer in vitro.
    Folkerd EJ; Reed MJ; James VH
    J Steroid Biochem; 1982 Feb; 16(2):297-302. PubMed ID: 7078166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.
    MacNeill FA; Jacobs S; Lønning PE; Powles TJ; Dowsett M
    Br J Cancer; 1994 Jun; 69(6):1171-5. PubMed ID: 8198987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen and oestrogen dynamics in hyperthyroidism.
    Ridgway EC; Maloof F; Longcope C
    J Endocrinol; 1982 Oct; 95(1):105-15. PubMed ID: 7130886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of aromatase and sulphatase in breast tumour cells.
    Purohit A; Wang DY; Ghilchik MW; Reed MJ
    J Endocrinol; 1996 Sep; 150 Suppl():S65-71. PubMed ID: 8943789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.
    Dowsett M; Santner SJ; Santen RJ; Jeffcoate SL; Smith IE
    Br J Cancer; 1985 Jul; 52(1):31-5. PubMed ID: 4015950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies.
    James VH; McNeill JM; Lai LC; Newton CJ; Ghilchik MW; Reed MJ
    Steroids; 1987; 50(1-3):269-79. PubMed ID: 3509763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of [3H]oestradiol in vivo by normal breast and tumour tissue in postmenopausal women.
    Bonney RC; Reed MJ; Beranek PA; Ghilchik MW; James VH
    J Steroid Biochem; 1986 Jan; 24(1):361-4. PubMed ID: 3702419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of glucocorticoids on the in vivo conversion of androstenedione to oestrone.
    Reed MJ; Beranek PA; Franks S; James VH
    Horm Metab Res; 1986 Sep; 18(9):635-7. PubMed ID: 3023227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of CGS 16949A on peripheral aromatisation in breast cancer patients.
    Lønning PE; Jacobs S; Jones A; Haynes B; Powles T; Dowsett M
    Br J Cancer; 1991 May; 63(5):789-93. PubMed ID: 1828173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of [1,2-3H,4-14C]16 alpha-hydroxyandrostenedione and its use for radiometric determination of human placental aromatase activity.
    Numazawa M; Tsuji M; Yarborough C; Osawa Y
    Chem Pharm Bull (Tokyo); 1987 Jun; 35(6):2448-52. PubMed ID: 3664841
    [No Abstract]   [Full Text] [Related]  

  • 32. A radiometric assay method for aromatase activity using [1 beta-3H]16 alpha-hydroxyandrostenedione.
    Numazawa M; Mutsumi A; Nakakoshi M; Nagaoka M
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1839-42. PubMed ID: 1394701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in the metabolism of oestrogens during treatment with aminoglutethimide in breast cancer patients. Preliminary findings.
    Lønning PE; Kvinnsland S; Thorsen T; Ueland PM
    Clin Pharmacokinet; 1987 Dec; 13(6):393-406. PubMed ID: 3436111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism.
    Brodie AM; Son C; King DA; Meyer KM; Inkster SE
    Cancer Res; 1989 Dec; 49(23):6551-5. PubMed ID: 2479464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between 17 beta-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue.
    Bonney RC; Reed MJ; Davidson K; Beranek PA; James VH
    Clin Endocrinol (Oxf); 1983 Dec; 19(6):727-39. PubMed ID: 6317235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-Hydroxyandrostenedione treatment for postmenopausal patients with breast cancer.
    Coombes RC
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):145-8. PubMed ID: 1525056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The aromatization of androgens by primary monolayer cultures of fetal rat hypothalamus.
    Canick JA; Vaccaro DE; Ryan KJ; Leeman SE
    Endocrinology; 1977 Jan; 100(1):250-3. PubMed ID: 830543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of 19-hydroxy-delta4-androstene-3,17-dione in the conversion of circulating delta4-androstene-3, 17-dione to estrone.
    Kelly WG; De Leon O; Rizkallah TH
    J Clin Endocrinol Metab; 1976 Jul; 43(1):190-4. PubMed ID: 947937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of tissue steroids in regulating aromatase and oestradiol 17 beta-hydroxysteroid dehydrogenase activities in breast and endometrial cancer.
    James VH; McNeill JM; Beranek PA; Bonney RC; Reed MJ
    J Steroid Biochem; 1986 Nov; 25(5B):787-90. PubMed ID: 3807364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exemestane, a new steroidal aromatase inhibitor of clinical relevance.
    Lombardi P
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):326-37. PubMed ID: 12084475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.